Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise M Boudreau

Showing results (11-20 of 103) with videos related to

Pageof 11
Sort By:
The American Journal of Medicine|September 6, 2016
Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community SettingRagan Hart, David L Veenstra, Denise M Boudreau, et al.
Pharmacoepidemiology and Drug Safety|April 16, 2009
Colorectal cancer risk in relation to use of acid suppressive medicationsJessica Chubak, Denise M Boudreau, Stephen J Rulyak, et al.
Cancer Causes & Control : CCC|March 7, 2008
Statin use and prostate cancer risk in a large population-based settingDenise M Boudreau, Onchee Yu, Diana S M Buist, et al.
Cancer Causes & Control : CCC|December 2, 2008
Statin use and female reproductive organ cancer risk in a large population-based settingOnchee Yu, Denise M Boudreau, Diana S M Buist, et al.
Journal of Medical Economics|December 24, 2016
The budget impact and cost-effectiveness of defibrotide for treatment of veno-occlusive disease with multi-organ dysfunction in patients post-hematopoietic stem cell transplantDavid L Veenstra, Gregory F Guzauskas, Kathleen F Villa, et al.
Pharmacoepidemiology and Drug Safety|April 5, 2019
Risk of second breast cancer events with chronic opioid use in breast cancer survivorsDenise M Boudreau, Lu Chen, Onchee Yu, et al.
Journal of the National Cancer Institute|August 14, 2013
Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survivalJessica Chubak, Denise M Boudreau, Heidi S Wirtz, et al.
Preventive Medicine|August 19, 2007
Concordance of population-based estimates of mammography screeningDenise M Boudreau, Casey L Luce, Evette Ludman, et al.
Annals of Emergency Medicine|May 29, 2012
A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic strokeDenise M Boudreau, Greg Guzauskas, Kathleen F Villa, et al.
Epidemiology (Cambridge, Mass.)|June 5, 2013
Time scale in follow-up studies: considering disease prognosisJessica Chubak, Onchee Yu, Diana S M Buist, et al.
Pageof 11

Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
The American Journal of Medicine|September 6, 2016
Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community SettingRagan Hart, David L Veenstra, Denise M Boudreau, et al.
Pharmacoepidemiology and Drug Safety|April 16, 2009
Colorectal cancer risk in relation to use of acid suppressive medicationsJessica Chubak, Denise M Boudreau, Stephen J Rulyak, et al.
Cancer Causes & Control : CCC|March 7, 2008
Statin use and prostate cancer risk in a large population-based settingDenise M Boudreau, Onchee Yu, Diana S M Buist, et al.
Cancer Causes & Control : CCC|December 2, 2008
Statin use and female reproductive organ cancer risk in a large population-based settingOnchee Yu, Denise M Boudreau, Diana S M Buist, et al.
Journal of Medical Economics|December 24, 2016
The budget impact and cost-effectiveness of defibrotide for treatment of veno-occlusive disease with multi-organ dysfunction in patients post-hematopoietic stem cell transplantDavid L Veenstra, Gregory F Guzauskas, Kathleen F Villa, et al.
Pharmacoepidemiology and Drug Safety|April 5, 2019
Risk of second breast cancer events with chronic opioid use in breast cancer survivorsDenise M Boudreau, Lu Chen, Onchee Yu, et al.
Journal of the National Cancer Institute|August 14, 2013
Threats to validity of nonrandomized studies of postdiagnosis exposures on cancer recurrence and survivalJessica Chubak, Denise M Boudreau, Heidi S Wirtz, et al.
Preventive Medicine|August 19, 2007
Concordance of population-based estimates of mammography screeningDenise M Boudreau, Casey L Luce, Evette Ludman, et al.
Annals of Emergency Medicine|May 29, 2012
A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic strokeDenise M Boudreau, Greg Guzauskas, Kathleen F Villa, et al.
Epidemiology (Cambridge, Mass.)|June 5, 2013
Time scale in follow-up studies: considering disease prognosisJessica Chubak, Onchee Yu, Diana S M Buist, et al.
Pageof 11